Northern Cyprus surveillance shows uneven infectious disease signals over a decade
Northern Cyprus has long sat outside the main current of published infectious-disease surveillance, and this analysis fills an important gap by rebuilding a decade of official notifiable-disease data into a more comparable series. The work spans 2014 through 2024, with 2025 retained only for descriptive context, and it focuses on how infection patterns changed when case definitions, diagnostic practices, and reporting structures shifted over time. In public health terms, that distinction matters because a rise in notifications can reflect transmission, but it can also reflect a cleaner reporting system, broader testing, or a revised disease category. The investigators addressed that problem directly by harmonizing the surveillance records rather than treating every annual total as if it were interchangeable.
The result is not a single epidemic curve but a set of disease-specific trajectories. Some infections stayed sparse throughout the study period, while others moved in abrupt spurts that are difficult to dismiss as background noise. Tuberculosis stood out most sharply, with the clearest recent jump in the entire dataset. A smaller set of vaccine-preventable and blood-borne infections also showed persistent or episodic activity, but the meaning of those numbers depends heavily on how the surveillance system classified them in each reporting era.
Tuberculosis rose from a low baseline to a markedly higher notification rate
The most striking signal came from tuberculosis. Notification rates moved from 0.44 per 100,000 in 2022 to 13.42 in 2023, then remained elevated at 9.32 in 2024. For a condition that often advances quietly and depends on case finding, that kind of shift raises immediate questions about delayed diagnosis, improved ascertainment, imported cases, or a genuine rise in transmission. Whatever the mechanism, the change is too large to ignore in routine public-health planning.
A tuberculosis surge at this scale has direct operational consequences. Contact tracing, sputum testing, chest imaging, and treatment follow-up all become more demanding once a low-incidence setting loses stability. Even before the precise driver is established, health systems have to prepare for the possibility that case detection is no longer capturing only isolated events. In a small population, a handful of additional cases can produce a dramatic rate change, but the jump described here is large enough to warrant a serious epidemiologic response rather than a passive watch-and-wait approach.
Measles returned after 2022 while varicella stayed unstable but non-monotonic
Among the vaccine-preventable infections, measles showed episodic activity, with renewed notifications after 2022. The abstract does not provide annual counts for measles, but the return of notifications after a period of quieter activity is clinically important because measles tends to expose any weakness in immunization coverage and outbreak containment. Even a small cluster can spread rapidly in settings where importation, household mixing, and uneven vaccination coverage intersect.
Varicella followed a different pattern. Notifications fluctuated substantially across the study period, yet the adjusted trend did not show a significant monotonic increase or decrease. The modeled notification rate ratio was 0.844, with a 95% confidence interval of 0.664 to 1.074 and a p value of 0.169. In practical terms, the data do not support a steady directional trend after adjustment for overdispersion. Instead, varicella behaved like an unstable signal, one shaped more by year-to-year variation than by a clean linear slope.
Viral hepatitis and HIV/STI trends were constrained by changing definitions
Interpretation became more complicated for viral hepatitis and the HIV/STI group. Surveillance-definition changes strongly influenced these series, which means the raw totals cannot be read as straightforward evidence of epidemiologic rise or fall. A category that changes its boundaries over time can create the illusion of a trend where none exists, or hide one that is real. This is exactly where harmonization becomes more than a technical detail. It becomes the difference between measuring disease and measuring paperwork.
The authors separated non-equivalent categories into different reporting eras, a necessary step when the administrative framework itself is unstable. That approach preserves comparability better than forcing incompatible definitions into a single line graph. It also reflects a basic principle of outbreak intelligence: laboratory confirmation, notification rules, and denominator quality must move together if the final rate is to mean anything useful. The analysis used official Statistical Institute data for independent cross-validation of selected annual totals and for population denominators, which strengthens confidence in the broad surveillance patterns even when the underlying disease definitions remain imperfect.
Why harmonized surveillance matters in a small Eastern Mediterranean setting
Northern Cyprus has been underrepresented in multi-disease surveillance literature, and that underrepresentation has real consequences. Without a consolidated baseline, it becomes difficult to distinguish a true epidemiologic shift from a reporting artifact, especially when a jurisdiction revises its disease categories or expands laboratory access. This study provides the first comprehensive harmonized multi-disease analysis of official surveillance in the setting, creating a reference point for future comparisons.
The broader public-health lesson is direct. Stable case definitions, compatible denominators, and stronger laboratory linkage are not optional refinements; they are the infrastructure that lets health authorities see what is actually happening. Infections that remain sparse can be ignored only at the cost of missing early change. Infections that become episodic, like measles, can warn of waning population immunity. And infections that jump as abruptly as tuberculosis did here may reveal delayed detection, improved ascertainment, or a real expansion in burden, each of which demands a different response.
The surveillance baseline now exists, but the analytic limitations remain visible
This study also shows the limits of ecological surveillance when reporting systems evolve in parallel with disease activity. Formal modeling was restricted to sufficiently stable series, which is methodologically appropriate but leaves some questions unresolved for categories shaped by changing definitions. The 2025 data were retained only descriptively, so the main analytic window still centers on 2014–2024. Even with those constraints, the dataset makes one point unmistakable: Northern Cyprus does not show a uniform infectious-disease pattern across the decade.
What emerges instead is a fragmented profile of low-level persistence, episodic vaccine-preventable activity, and a pronounced recent tuberculosis rise. That profile is exactly why harmonized surveillance is valuable. It provides a way to separate biological signal from administrative noise, and it gives public-health teams a starting point for targeted action rather than a vague impression of change.